Sponsored
by CENTOGENE
How Can We Improve the Diagnosis and Treatment of Rare Diseases?
More people are impacted by rare diseases than by cancer and AIDS combined. With 400…
February 17, 2020 - 7 minutes
Rare disease
First-in-Class Drug For Inherited Metabolic Diseases Funded with €25M
The Dutch startup Azafaros has raised €25M in Series A funding to push its drug…
February 10, 2020 - 2 minutes
Harnessing Genetic Suppression to Treat Rare Disease
Through quirks of genetics, some people are naturally resilient to heritable diseases. Thijn Brummelkamp, Managing…
February 5, 2020 - 5 minutes
Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III
A small molecule drug developed by the US company ChemoCentryx and its Swiss partner Vifor…
November 26, 2019 - 3 minutes
Mereo BioPharma’s Brittle Bone Disease Drug Stumbles in Phase II
The lead drug of the UK company Mereo BioPharma has achieved mixed results in a…
November 11, 2019 - 2 minutes
€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics
The German company Centogene has raised €50.6M ($56M) in an IPO on the Nasdaq Stock…
November 7, 2019 - 2 minutes
UK Firm Raises €51M to Repurpose Drugs for Rare Diseases Using AI
The Cambridge-based artificial intelligence company Healx has raised a Series B round of €50.8M to…
October 16, 2019 - 2 minutes
This Biotech Targets Mitochondria to Treat Inherited Diseases
As we come to the end of the global Mitochondrial Disease Awareness Week, it’s time…
September 20, 2019 - 3 minutes
Dutch Company Raises €60M to Treat Inherited Inflammatory Disease
The Dutch pharmaceutical company Pharvaris has raked in €60M in a Series B round to…
September 11, 2019 - 2 minutes
First Gene Therapy for Beta Thalassemia Approved in Europe
The US biotech company bluebird bio has obtained EU conditional market approval for a gene…
June 4, 2019 - 3 minutes
This Biotech Treats a Neurological Autoimmune Disorder Using DNA
We’re jumping into Poland this week. Pure Biologics is a biotech based in Wrocław developing…
May 31, 2019 - 4 minutes
Pfizer Pays up to €700M to Acquire Swiss Biotech Restoring Bone Growth in Achondroplasia
Pharma giant Pfizer is acquiring the Swiss biotech Therachon, which is developing a protein drug…
May 9, 2019 - 2 minutes
